Article approval pendingAntiretroviral treatment (ART) coverage in Myanmar is well below average. This study describes retention and baseline predictors of prognosis from the largest ART program in the country

Bisson

Braitstein

Brinkhof

Coetzee

Cornell

Deeks

Egger

Ferradini

Frank Smithuis

Ivers

Kalpana Sabapathy

Kazatchkine

Keiser

Khin Nyein Chan

Komatsu

Madec

McGuire

Moe Kyaw Kyaw

Nathan Ford

Riekje Elema

Sian Floyd

Thai

Van Cutsem

Williams

Zachariah

Zhang

English

BACKGROUND: Antiretroviral treatment (ART) coverage in Myanmar is well below average. This study describes retention and baseline predictors of prognosis from the largest ART program in the country. METHODS: A cohort analysis of adult patients who initiated ART during 2003-2007 was conducted, with follow-up until the end of 2009. The primary outcome was attrition [death plus losses to follow-up (LTF)]. Baseline variables were assessed as potential risk factors. The cumulative probabilities of death, LTF, and attrition up to 5 years were described using Kaplan-Meier estimates. Cox regression was used to calculate hazard ratios of attrition, overall and separately for 2 time periods on ART: 1-6 and 7-36 months. RESULTS: A total of 5963 adults enrolled in the program, providing 17,581 person-years of follow-up. Median age at baseline was 33 years [interquartile range (IQR): 28-38], 61% were men, 45% were in World Health Organization stage IV, and the median CD4 count was 71 cells per cubic millimeter (IQR: 29-164). There were 821 (13.8%) deaths and 389 (6.5%) LTF over the study period, with a 72% probability of being retained in care in the 5-year cohort. Double the rate of loss was contributed by death compared with LTF, and attrition was almost 4 times higher in the period 1-6 months compared with 7-36 months. In the multivariable analyses of the program overall, older age [adjusted hazard ratio (aHR): 1.56, 95% confidence interval (CI): 1.25 to 1.94], being male (aHR: 1.52, 95% CI: 1.25 to 1.85), World Health Organization stage IV (aHR: 1.44, 95% CI: 1.19 to 1.74), and body mass index 6 years in this large cohort demonstrates that ART delivery at the primary care level in Myanmar is feasible and should encourage support for further ART expansion in the country

Sabapathy, Kalpana

Ford, Nathan

Chan, Khin Nyein

Kyaw, Moe Kyaw

Elema, Riekje

Smithuis, Frank

Floyd, Sian

LSHTM Research Online

Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.

Crossref

JAIDS Journal of Acquired Immune Deficiency Syndromes

Treatment Outcomes From the Largest Antiretroviral Treatment Program in Myanmar (Burma)

MSF Field Research

An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs.

Antiretroviral therapy in resourcelimited settings

Asia can afford universal access for AIDS prevention and treatment.

Available at: http://www.who.int/hiv/pub/arv/adult/en/index.html.

Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis. PLoS One.

Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.

Development Programme. Human Development Report—International Human Development Indicators.

Development Programme. Human Development Report. Overcoming barriers: human mobility and development.

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ.

Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis.

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis.

Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia. Trop Med Int Health.

HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resourcelimited settings: systematic review and meta-analysis. PLoS One.

Organization, Joint United Nations Programme on HIV/ AIDS, UniCEF. Global HIV/AIDS response: epidemic update and health sector progress towards universal access, Progress Report.

Organization, Regional Office for South-East Asia. Myanmar: TB Country Profile. Yangon, Myanmar: World Health Organization;

Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach.

Organization. Guidelines on co-trimoxazole prophylaxis for HIV related infections amongst children, adolescents and adults. Recommendations for a public health approach.

Organization. Scaling-up antiretroviral therapy in resource limited settings. Guidelines for a public health approach.

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.

Overestimates of survival after HAART: implications for global scale-up efforts. PLoS One.

Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health.

Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia.

Response to highly active antiretroviral therapy among severely immuno-compromised HIVinfected patients in Cambodia.

Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi.

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa,

Very early mortality in patients starting antiretroviral treatment at primary health centres in rural Malawi. Trop Med Int Health.

Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health.

Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.

Abstract

Similar works

Full text

Available Versions

LSHTM Research Online

Crossref

MSF Field Research